Molecular Diagnostic Platforms

November 2021 - Vol.10 No. 10 - Page #32
Category: Molecular Diagnostics

The flourishing field of molecular diagnostics enjoys a deep marketplace of automation platforms and testing options. As clinical utility and validity are key to widespread implementations, the ongoing collaboration between clinical providers and the laboratory in determining when molecular testing is appropriate and how best to interpret the results will remain essential to delivering personalized medicine.


The use of molecular diagnostic platforms has grown each of the last three years, reaching 7 out of 10 facilities in 2021.

Satisfaction with molecular diagnostics platforms is strong and steady, as zero facilities indicate they are less than satisfied for the second year in a row.

In one of the more prolific marketplaces, Cepheid and BioFire Diagnostics lead the vendors in use, with several other well known suppliers in the mix.

Click here to view a larger version of this Chart.



Like what you've read? Please log in or create a free account to enjoy more of what has to offer.

Current Issue